Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | Genetic profiling: the key to Huntington’s treatment?

Lesley Jones • 20 Mar 2019
ARUK 2019
Huntington’s Disease Movement Disorders

Lesley Jones, PhD, of Cardiff University, Cardiff, UK, discusses how the genetic profiling of patients with Huntington’s disease can be used to create pharmaceutical treatments for the disease. Prof. Jones also goes on to discuss cutting-edge clinical trials taking place that are seeking good therapeutic outcomes for patients. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK.

More from Lesley Jones

5:03
FAN1 modifies Huntington’s disease progression
Lesley Jones • 20 Mar 2019
1:30
Neurogenetics of Huntington’s disease onset
Lesley Jones • 20 Mar 2019

Related Videos

1:19
The potential of cell and gene therapy in treating Parkinson’s disease
Fabrizio Stocchi • 7 Mar 2024
4:11
Updates on current Parkinson’s disease clinical trials
Fabrizio Stocchi • 7 Mar 2024
3:42
NfL shows strong prognostic value in pre-manifest Huntington's disease
Natalia E. Owen • 8 Mar 2024
5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
The content of VJNeurology is intended for healthcare professionals